MANTA Registry for Vascular Large-bore Closure — MARVEL

Femoral Arteriotomy Closure Clinical Trial

Official title:
Post-Market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)

Status Completed

Clinical Trial Summary

The aim of this observational post market study is to compile real world outcome data on the use of the Conformité Européenne (CE) marked MANTA Vascular Closure Device following percutaneous cardiac or peripheral procedures for large bore (10-18F ID) interventional devices.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Femoral Arteriotomy Closure

Clinical Trial Details

NCT number	NCT03330002
Study type	Observational [Patient Registry]
Source	Essential Medical, Inc.
Contact
Status	Completed
Phase
Start date	February 23, 2018
Completion date	February 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05936996` - Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
Not yet recruiting	`NCT06358157` - The Ladera Large Bore Closure Feasibility Study	N/A
Completed	`NCT02521948` - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device	N/A
Completed	`NCT02908880` - MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study	N/A
Terminated	`NCT05142566` - MANTA Ultrasound Closure Study	N/A
Completed	`NCT02406612` - X-Seal EU Post-Market Clinical Follow-Up Protocol	N/A